Trimethylamine N-oxide (TMAO), which is produced from trimethylamine (TMA) stemming from OCT substrates choline and carnitine from protein and lipid nutrients converted by microbiota in the gut, is associated with cardiovascular disease, and thus considered to be a potential novel pro-atherosclerotic molecule [173,174]. Here, PLXNA2 is linked to cardiovascular disorder.